Medical Countermeasures Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense PreparednessGlobal Biodefense StaffSeptember 9, 2025
Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Protein Sciences Awarded DoD Grant for Novel Adenovirus Vaccine Contracts + Grants November 13, 2015 …
NIAID Awards Contract to Develop Treatments for Radiation Exposure Contracts + Grants October 26, 2015 …
CIDR-GSK Partnership Spotlights Antifolates for TB Drug Discovery Medical Countermeasures October 15, 2015 …
